Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05658536 · ClinicalTrials.gov registry record · NA

The COPE Study: Pilot Intervention to Improve Symptom Self-management and Coping in Adults With Post COVID-19

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
51
Enrollment target

NCT05658536 is a NA study that has completed, run by University of Washington. The registered enrollment target is 51 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05658536, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target

Study Summary

This project is a randomized controlled pilot trial using mixed methods to examine the feasibility, acceptability, and initial effects of a telemedicine group-based intervention designed to improve symptom management and coping in adults with Post-COVID.

Interventions

  • BEHAVIORAL 6-Week Self-Management Group

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2023-01-18
Est. Completion 2024-01-30
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT05658536

The ClinicalTrials.gov registry entry for NCT05658536 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which 6-Week Self-Management Group is the first listed.

NCT05658536 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05658536 about?

NCT05658536 is a clinical study titled "The COPE Study: Pilot Intervention to Improve Symptom Self-management and Coping in Adults With Post COVID-19". This project is a randomized controlled pilot trial using mixed methods to examine the feasibility, acceptability, and initial effects of a telemedicine group-based intervention designed to improve symptom management and coping in adults with Post-COVID.

What is the current status of trial NCT05658536?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2023-01-18. Estimated completion is 2024-01-30.

What interventions are being tested in trial NCT05658536?

The interventions under investigation include: 6-Week Self-Management Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT05658536?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.